CHAI

New consortium of healthcare leaders announces formation of Trustworthy & Responsible AI Network (TRAIN), making safe and fair AI accessible to every healthcare organization

Retrieved on: 
Monday, March 11, 2024
Informatics, Algorithm, Responsibility, Information technology, Health, Biomedical Research, Patient, Cleveland Clinic, Approximation error, Artificial intelligence in healthcare, Microsoft, Public, AdventHealth, Mass General Brigham, Coalition, Science, Policy, Safety, Boston Children's Hospital, VUMC, Organization, Bias, Trust (social science), Research, AI, University, Nouvelle AI, MPH, Vanderbilt University Medical Center, Hospital, Sharp HealthCare, Internal medicine, Health informatics, Conference, Public health, Cardiology, Caregiver, MedStar Health, CHAI, HIMSS, Mount Sinai Health System, Medical device

New AI capabilities have the potential to transform the healthcare industry by enabling better care outcomes, improving efficiency and productivity, and reducing costs.

Key Points: 
  • New AI capabilities have the potential to transform the healthcare industry by enabling better care outcomes, improving efficiency and productivity, and reducing costs.
  • Enabling registration of AI used for clinical care or clinical operations through a secure online portal.
  • "By working together, TRAIN members aim to establish best practices for operationalizing responsible AI, helping improve patient outcomes and safety while fostering trust in healthcare AI."
  • "We are excited to join our TRAIN partners in the journey to accelerate AI innovation in an ethical, responsible and safe way."

COALITION FOR HEALTH AI (CHAI) NAMES BOARD OF DIRECTORS AND CEO

Retrieved on: 
Monday, March 4, 2024
Disability, CHAI, Generative, Government, NHC, Health care, Human, MITRE, Organization, Policy, Duke, Algorithm, Coalition, Forecasting, Food and Drug Administration, Ecosystem, HL7, Machine learning, MBBS, Carnegie Mellon University, Partnership, Chairperson, National Health Council, Learning, Technology policy, Safety, MPH, Conditional sentence, Commissioner, Research, Human services, Stanford University Medical Center, MPP, Workgroup, AI, FDA, Food, Veterans Health Administration, National academy, Artificial intelligence in healthcare, Communication, Doctor of Philosophy, Medicare, Patient, Duke University, Biostatistics, Medicine, Privacy, Publication, Medical device

WASHINGTON, March 4, 2024 /PRNewswire/ -- Today CHAI, the Coalition for Health AI, announced Dr. Brian S. Anderson, a CHAI co-founder and chief digital health physician at MITRE, to be its first CEO. It also named members of CHAI's inaugural Board of Directors chaired by Dr. John Halamka, a CHAI co-founder and the president of Mayo Clinic Platform, as well as leaders of key advisory boards. CHAI includes representatives from over 1300 member organizations including hospital systems, tech, government agencies and advocacy groups. The board also opened general membership for individuals and organizations and formalized the process for joining and contributing to CHAI work groups.

Key Points: 
  • CHAI today also announced partnerships with the patient advocacy group, the National Health Council, and health standards organization, HL7.
  • To implement this commitment, CHAI established a governance structure extending beyond the Board of Directors to include a small number of strategically defined advisory boards.
  • I am excited to be a part of the Coalition for Health AI to help create a future where responsible AI practices are the cornerstone."
  • – Michael Pencina, board member
    "Decades of research have brought us to a transformative moment for AI and the applications in medicine are unbounded.

John Snow Labs is All In on Generative AI, Achieving 82M Spark NLP Downloads, 5x NLP Lab Growth, and New State-of-the-Art LLM Accuracy Benchmarks

Retrieved on: 
Tuesday, January 23, 2024
ONNX, Classification, Report, Veterans' affairs, Privacy, Research, NLP, RAG, Coalition, OpenAI, AI, Bias, Oracle, GPT, Publishing, AWS, Medicine, Accenture, Hugging Face, CHAI, Organization, News, Azure, LLM, Medical device

The shift across John Snow Labs’ product suite has resulted in several notable company milestones over the past year including:

Key Points: 
  • The shift across John Snow Labs’ product suite has resulted in several notable company milestones over the past year including:
    82 million downloads of the open-source Spark NLP library.
  • John Snow Labs has won the 2024 Global 100 Award for the Best Medical Application of LLMs.
  • Additionally, John Snow Labs has developed a series of new integrations with partners to enable customers to build end-to-end solutions faster.
  • John Snow Labs now has 26 partners including Oracle, AWS, Azure, Deloitte, Carahsoft, Accenture, and Booz Allen Hamilton.

USAID Taps CHAI, GETF to Launch Coalition That Will Test Innovative Approaches to Address Antimicrobial Resistance in Low- and Middle-Income Countries

Retrieved on: 
Friday, January 12, 2024
Philanthropy, Health, Other Philanthropy, Other Health, Foundation, General Health, Pharmaceutical, Dependent and independent variables, USAID, Infection, International development, Therapy, CHAI, AMR, Medical device

The new coalition, the Antimicrobial Resistance Access and Stewardship Initiative (AMRASI), is a groundbreaking initiative that will use a sustainable, market-driven approach to address critical gaps in access to diagnostics and antimicrobials while incentivizing their appropriate use in low- and middle-income countries.

Key Points: 
  • The new coalition, the Antimicrobial Resistance Access and Stewardship Initiative (AMRASI), is a groundbreaking initiative that will use a sustainable, market-driven approach to address critical gaps in access to diagnostics and antimicrobials while incentivizing their appropriate use in low- and middle-income countries.
  • Following a series of convenings to align on these key pilot areas, the coalition aims to mobilize and launch the targeted pilot to test the model in up to two low- and middle-income countries.
  • GETF is serving as the AMRASI Secretariat, supporting the coalition to plan for pilot design in the first half of 2024.
  • "The AMRASI coalition provides a great opportunity to test innovative strategies to combat AMR and develop learnings that can be shared across the sector.

International Collaboration to Improve Cancer Care in Sub-Saharan Africa Updates Resources for Sixth Year

Retrieved on: 
Wednesday, December 20, 2023
Oncology, African, Conference, CHAI, Research, Breast, SSA, NCCN, MBA, ACC, Incidence, United, Prostate, American Cancer Society, Patient, ACS, Senior, Birth control

PLYMOUTH MEETING, Pa., Dec. 20, 2023 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading academic cancer centers in the United States—is celebrating six years of working alongside the African Cancer Coalition (ACC), the American Cancer Society (ACS), and the Clinton Health Access Initiative (CHAI), as part of Allied Against Cancer. The collaboration was formed to support and empower the Sub-Saharan African oncology community to advance health system capacity, deliver high-quality cancer care, and improve access for all patients.

Key Points: 
  • The collaboration was formed to support and empower the Sub-Saharan African oncology community to advance health system capacity, deliver high-quality cancer care, and improve access for all patients.
  • Allied Against Cancer's work involves several initiatives, including the development of NCCN Harmonized Guidelines™ for Sub-Saharan Africa.
  • "Allied Against Cancer activities and tools like the NCCN Harmonized Guidelines help us to ensure cancer care can be provided according to the latest research, based on all available resources.
  • The first NCCN Harmonized Guidelines™ for Sub-Saharan Africa debuted in November of 2017, during the biennial African Organisation for Research and Training in Cancer (AORTIC) International Conference on Cancer in Africa in Kigali, Rwanda.

International Collaboration to Improve Cancer Care in Sub-Saharan Africa Updates Resources for Sixth Year

Retrieved on: 
Wednesday, December 20, 2023
Oncology, African, Conference, CHAI, Research, Breast, SSA, NCCN, MBA, ACC, Incidence, United, Prostate, American Cancer Society, Patient, ACS, Senior, Birth control

PLYMOUTH MEETING, Pa., Dec. 20, 2023 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading academic cancer centers in the United States—is celebrating six years of working alongside the African Cancer Coalition (ACC), the American Cancer Society (ACS), and the Clinton Health Access Initiative (CHAI), as part of Allied Against Cancer. The collaboration was formed to support and empower the Sub-Saharan African oncology community to advance health system capacity, deliver high-quality cancer care, and improve access for all patients.

Key Points: 
  • The collaboration was formed to support and empower the Sub-Saharan African oncology community to advance health system capacity, deliver high-quality cancer care, and improve access for all patients.
  • Allied Against Cancer's work involves several initiatives, including the development of NCCN Harmonized Guidelines™ for Sub-Saharan Africa.
  • "Allied Against Cancer activities and tools like the NCCN Harmonized Guidelines help us to ensure cancer care can be provided according to the latest research, based on all available resources.
  • The first NCCN Harmonized Guidelines™ for Sub-Saharan Africa debuted in November of 2017, during the biennial African Organisation for Research and Training in Cancer (AORTIC) International Conference on Cancer in Africa in Kigali, Rwanda.

MarketVector Indexes Licenses the MCM-BlueStar® Israel Bonds Index to Defiance for the first-ever Israel Bond ETF (CHAI)

Retrieved on: 
Wednesday, December 13, 2023
Other Professional Services, Professional Services, Finance, Shekel, ETF, Corporation, ILS, NYSE, Government, Corporate bond, USD, CHAI, Partnership, Third government of Israel, United States dollar, Security (finance), Defiance, Index

MarketVector IndexesTM (“MarketVector”) announces the licensing of the MCM-BlueStar® Israel Bonds Index (MBILB) to Defiance ETFs .

Key Points: 
  • MarketVector IndexesTM (“MarketVector”) announces the licensing of the MCM-BlueStar® Israel Bonds Index (MBILB) to Defiance ETFs .
  • The firm today launched the Defiance Israel Bond ETF (NYSE Ticker: CHAI), a first-of-its-kind fund that invests in Israeli government and corporate bonds, offering diversified exposure to the Israeli fixed-income market.
  • The CHAI ETF will track the MCM-BlueStar® Israel Bonds Index.
  • “We are proud to partner with Defiance to support the launch of their innovative and pioneering Israel Bond ETF,” said Steven Schoenfeld, CEO of MarketVector.

CHAI, the First Israel Bond ETF, Launches Today on the New York Stock Exchange (NYSE)

Retrieved on: 
Wednesday, December 13, 2023
Professional Services, Finance, ETF, Funding, Distribution, ILS, NAV, Fund, Capital gain, Investment, Risk, USD, 7-day SEC yield, CHAI, Prospectus, Trust, Adviser, MCM, Loss, Government, Lovell Minnick Partners, Financial adviser, Security (finance), Insurance, Defiance, Index

The goal of the Israel Bond ETF is to provide liquid access to Israel government and corporate bonds.

Key Points: 
  • The goal of the Israel Bond ETF is to provide liquid access to Israel government and corporate bonds.
  • CHAI, the Defiance Israel Bond ETF , will track the MCM (Migdal Capital Markets) BlueStar Israel Bond Index.
  • The Defiance Israel Bond ETF (the “Fund” or the “Israel Bond ETF”) seeks to track the total return performance, before fees and expenses, of the BlueStar® USD Israel Bonds Index (the “Index”).
  • The BlueStar® USD Israel Bonds Index is predominantly composed of investment grade, U.S. dollar (“USD”)-denominated Israel Bonds.

Public Trust in AI Technology Declines Amid Release of Consumer AI Tools

Retrieved on: 
Tuesday, September 19, 2023
Technology, Artificial Intelligence, CHAI, Gen, Millennials, Public, Coalition, Identity theft, ChatGPT, Facial recognition, Woman, Microsoft, Generation Z, Government, Thought, Carnegie Mellon University, Engineering, Ecosystem, Transport, MITRE, News, Social media, Safety, Medical device, AI, Generation X

Generative artificial intelligence (AI) has dominated much of the public conversation about technology following the release of tools like ChatGPT and Jasper Chat.

Key Points: 
  • Generative artificial intelligence (AI) has dominated much of the public conversation about technology following the release of tools like ChatGPT and Jasper Chat.
  • In our second MITRE-Harris Poll survey on AI trends, conducted in July 2023, we found that aspects of public trust in AI technologies has declined compared to our previous poll, which was conducted in November 2022.
  • 85% want industry to transparently share AI assurance practices before bringing products equipped with AI technology to market.
  • MITRE is partnering with Carnegie Mellon University to address the adoption of AI decision-making tools that improve our response to disaster management, public health, and other societal challenges.

Critical agreement paves way for new model to accelerate access to important antibiotics for serious bacterial infections

Retrieved on: 
Tuesday, September 12, 2023
Oncology, Health, Genetics, Clinical Trials, Pharmaceutical, Biotechnology, CHAI, US Foods, Gram, Infection, European Medicines Agency, National Rural Development Partnership, Pharmaceutics, AMR, PQ, Cephalosporin, Patient, Tuberculosis, Diagnosis, WHO, Death, Food, World Health Organization, Essential medicines, Pharmaceutical industry, Shionogi, Orchid

Launched in June 2022, the project represents a new model for bridging global gaps in equitable access to important antibiotics.

Key Points: 
  • Launched in June 2022, the project represents a new model for bridging global gaps in equitable access to important antibiotics.
  • Even though populations in low- and middle-income countries face a high burden of death from drug-resistant bacterial infections, their access to antibiotics with activity against resistant bacteria is usually delayed by more than a decade .
  • That situation may worsen given that the number of serious, potentially life-threatening, infections due to carbapenem-resistant bacteria has been growing across multiple regions , including South Asia and Latin America.
  • By addressing barriers that have historically limited the availability of important antibiotics in low- and middle-income countries, this innovative project aims to accelerate appropriate access for an affordable, quality-assured antibiotic to treat drug-resistant Gram-negative infections.